Innospec Inc. filings document the financial reporting, governance and capital-return disclosures of a specialty chemicals operating company. Form 8-K reports record quarterly and annual results, segment commentary for Performance Chemicals, Fuel Specialties and Oilfield Services, Regulation FD disclosures, semi-annual dividends and board-authorized common stock repurchase programs.
The company’s proxy materials describe annual meeting matters, director elections, executive compensation votes, auditor ratification and related governance procedures. Its filings also identify IOSP common stock as a NASDAQ-listed security and provide formal disclosure around results of operations, financial condition, risk-related business context and shareholder voting matters.
Allspring Global Investments Holdings, LLC reported beneficial ownership of 1,161,421 shares of Innospec Inc. (IOSP) common stock, or 4.7%, as of September 30, 2026. It reported sole voting power over 1,160,597 shares and sole dispositive power over 1,161,421 shares; shared voting and dispositive power were each 0. The shares are held of record by clients of Allspring’s investment-adviser subsidiaries, who have rights to receive dividends or direct sale proceeds. No client was known to have those rights over more than 5% of the class.
Allspring Global Investments Holdings, LLC reported beneficial ownership of 1,161,421 Innospec Inc. common shares, or 4.7% of the class, as of September 30, 2026. It reported sole voting power over 1,160,597 shares and sole dispositive power over 1,161,421 shares; shared voting and dispositive powers were each zero. The shares are owned of record by clients of investment advisers identified in Exhibit A. Those clients have the right to receive, or power to direct receipt of, dividends or sale proceeds.
Innospec Inc. reported that Corbin Barnes, SVP, Corporate Dev and IR, received an award of 2,642 phantom stock shares on October 1, 2026. Each phantom share is the economic equivalent of one IOSP common share, and the reported post-transaction position is 2,642 phantom stock shares. The award vests, subject to continued employment and satisfactory performance, in installments of 25% on February 1, 2027, 25% on October 1, 2027, and 50% on October 1, 2028.
Innospec Inc. (IOSP) reported that Hardy Louis Griffin III, SVP, Human Resources, acquired an award of 2,685 shares of phantom stock on October 1, 2026. Each phantom share is the economic equivalent of one share of IOSP common stock. The award vests 25% on February 1, 2027, 25% on October 1, 2027, and 50% on October 1, 2028, subject to his continued employment and satisfactory performance.
Innospec Inc. (IOSP) reports that EVP & CFO Ian Cleminson received an award of 4,792 phantom stock units on October 1, 2026; the reported resulting phantom-stock position was 4,792 units. Each unit is the economic equivalent of one IOSP common share. The award vests subject to continued employment and satisfactory performance: 25% on February 1, 2027, 25% on October 1, 2027, and 50% on October 1, 2028.
Innospec Inc. (IOSP) granted Senior VP R&T Ian Malcolm McRobbie 3,164 shares of phantom stock on October 1, 2026. The award is scheduled to vest 25% on February 1, 2027, 25% on October 1, 2027, and 50% on October 1, 2028, subject to continued employment and satisfactory performance.
Innospec Inc. SVP, GC & CCO David B. Jones acquired a direct award of 3,188 phantom shares on October 1, 2026. Each phantom share is the economic equivalent of one common share. The award vests subject to Jones’s continued employment and satisfactory performance.
Innospec Inc. reported that its President & CEO, Patrick Williams, was granted 22,203 shares of phantom stock on October 1, 2026, bringing his reported direct phantom-stock position to 22,203 shares. Each phantom share is the economic equivalent of one share of IOSP common stock. The award vests in installments, subject to continued employment and satisfactory performance, and expires October 1, 2028.
Innospec Inc. reported higher results for the quarter ended June 30, 2026. Net sales rose to $491.4 million from $439.7 million, and net income attributable to Innospec increased to $30.8 million, with diluted EPS of $1.25 versus $0.94 a year earlier.
All three segments grew sales: Performance Chemicals to $190.3 million, Fuel Specialties to $185.7 million, and Oilfield Services to $115.4 million, with Oilfield Services showing the strongest gross margin improvement. Six‑month operating cash flow declined to $24.8 million from $38.8 million, mainly from higher receivables and inventory. Cash and cash equivalents were $250.2 million, and the company had no borrowings under its $250.0 million multicurrency revolving credit facility. Innospec paid $22.7 million in dividends, repurchased $13.5 million of stock, carries plant closure provisions of $64.7 million, and continues to pursue civil and criminal claims related to a prior inventory misappropriation in Brazil with no significant new developments.
Innospec Inc. reported solid second-quarter 2026 results with broad-based growth across all segments. Total revenue was $491.4 million, up 12 percent from $439.7 million a year earlier. Net income attributable to Innospec rose to $30.8 million, and diluted GAAP EPS increased to $1.25 from $0.94. Adjusted non-GAAP EPS was $1.27, slightly above $1.26 last year, while adjusted EBITDA was $50.1 million versus $49.1 million.
Performance Chemicals revenue grew 9 percent to $190.3 million with operating income up 15 percent. Fuel Specialties revenue increased 12 percent to $185.7 million, and Oilfield Services revenue rose 14 percent to $115.4 million, with operating income in that segment up 40 percent. The quarter ended with a debt‑free balance sheet and $250.2 million in cash and cash equivalents. Operating cash flow for the quarter was $7.2 million. Innospec returned capital through a semi‑annual dividend of $0.92 per share (about $22.7 million) and share repurchases of 87,089 shares for $6.4 million.